| Health / Medical Topics |
PSA:154-163(155L) Peptide Vaccine
A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163 (155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA. (NCI Thesaurus)
YOU MAY ALSO LIKE
A synthetic peptide based on sequence corresponding to positions 154-163 of the amino acids of prostate-specific antigen (PSA), VISNDVCAQV. Upon administration, PSA:154-163…
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with the prostate-specific tumor associated antigens (TAAs) prostate specific antigen (PSA)…
A 30-residue prostate specific antigen (PSA) oligoepitope peptide (OP) vaccine with potential antineoplastic activity. PSA-OP peptide vaccine contains the PSA-1 and…
A measurement of how fast PSA levels in the blood increase over time. A high PSA velocity may be a sign of…
A laboratory test that measures the amount of prostate-specific antigen (PSA) found in the blood. PSA is a protein made by the…
An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA…
